Artoss
-
Regulatory
Artoss, Inc. Announces FDA Clearance of NanoBone® SBX Putty for Standalone Use in Posterolateral Spinal Fusion
April 24, 2019 Artoss, Inc. is pleased to announce that the US Food & Drug Administration has cleared NanoBone SBX…
Read More » -
Biologics
Artoss Announces FDA Clearance to Market of NanoBone® SBX Putty
November 8, 2016 Artoss, Inc. is pleased to announce that, on October 26, 2016, Artoss GmbH received notice from the…
Read More »